Who are Elanco Animal Health Incorporated's main suppliers?

Elanco Animal Health Incorporated (ELAN) key suppliers include: AHV-INTERNATIONAL-B-V, Merck & Co., Inc., Merck & Co., Inc., Tarsus Pharmaceuticals, Inc.. View the full supplier network at chainsifter.com/chain/ELAN.

Who are Elanco Animal Health Incorporated's major customers?

Elanco Animal Health Incorporated (ELAN) key customers include: Blackstone Inc., Blackstone Inc., TARSUS-PHARMACEUTICALS-INC, Eli Lilly and Company, Eli Lilly and Company and 7 more. View the full customer network at chainsifter.com/chain/ELAN.

What sector is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated (ELAN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Elanco Animal Health Incorporated Suppliers, Customers & Supply Chain (ELAN)

4Suppliers

12Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Elanco Animal Health Incorporated (ELAN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships

3Distinct source URLs

6High confidence

0.752Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Elanco Animal Health Incorporated Suppliers

Ticker	Name	Confidence	Evidence
AHV-INTERNATIONAL-B-V	AHV-INTERNATIONAL-B-V	85%	On April 30, 2026, we completed the previously announced acquisition of 100 % of the outstanding equity interests of AHV International B.V. (AHV)
MRK	Merck & Co., Inc.	72%	utical production processes are complex, highly regulated and can vary widely from product to product. Shifting or adding manufacturing capacity can be a lengthy process requiring significant capital…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from ELAN graph: utical production processes are complex, highly regulated and can vary widely from product to product. Shifting or add…
TARS	Tarsus Pharmaceuticals, Inc.	62%	Reciprocal relationship from TARS graph: ation of our product or our product candidates, including XDEMVY for the treatment of Demodex blepharitis, TP-04 for the potential treatment of ocular rosacea…

Elanco Animal Health Incorporated Customers

Ticker	Name	Confidence	Evidence
BX	Blackstone Inc.	92%	Reciprocal relationship from BX graph: Reciprocal relationship from ELAN graph: In May 2025, we executed a Purchase and Sale Agreement (PSA) with funds affiliated with Blackstone Life Sciences and Bl…
BX	Blackstone Inc.	92%	In May 2025, we executed a Purchase and Sale Agreement (PSA) with funds affiliated with Blackstone Life Sciences and Blackstone Credit & Insurance (collectively, Blackstone).
TARSUS-PHARMACEUTICALS-INC	TARSUS-PHARMACEUTICALS-INC	90%	These payments are made by Tarsus to Blackstone through a third-party escrow account
LLY	Eli Lilly and Company	72%	services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in …
LLY	Eli Lilly and Company	72%	Reciprocal relationship from LLY graph: Reciprocal relationship from ELAN graph: services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and…
MRK	Merck & Co., Inc.	72%	utical production processes are complex, highly regulated and can vary widely from product to product. Shifting or adding manufacturing capacity can be a lengthy process requiring significant capital…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from ELAN graph: Reciprocal relationship from MRK graph: Reciprocal relationship from ELAN graph: Reciprocal relationship from MRK grap…
TARS	Tarsus Pharmaceuticals, Inc.	72%	Reciprocal relationship from TARS graph: Reciprocal relationship from ELAN graph: Reciprocal relationship from TARS graph: Reciprocal relationship from ELAN graph: Reciprocal relationship from TARS g…
BEXCAFE-LLC	BEXCAFE-LLC	62%	isting nutritional health offerings and further our efforts to explore innovative antibiotic alternatives. The composition of the purchase price was as follows: Up-front cash consideration $ 16 Defer…
BUSINESS-OVERVIEW-ELANCO-ANIMAL-HEALTH-INCORPORA	BUSINESS-OVERVIEW-ELANCO-ANIMAL-HEALTH-INCORPORA	62%	law. 5 Table of Contents PART I ITEM 1. BUSINESS Overview Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal healt…
NUTRIQUEST-LLC	NUTRIQUEST-LLC	62%	22 United States $ 2,036 $ 1,983 $ 1,965 International 2,403 2,434 2,446 Revenue $ 4,439 $ 4,417 $ 4,411 We have a single customer that accounted for approximately 11 %, 10 % and 11 % of revenue for …
TRIRX-SPEKE-LTD	TRIRX-SPEKE-LTD	62%	22 United States $ 2,036 $ 1,983 $ 1,965 International 2,403 2,434 2,446 Revenue $ 4,439 $ 4,417 $ 4,411 We have a single customer that accounted for approximately 11 %, 10 % and 11 % of revenue for …

Elanco Animal Health Incorporated Debt Obligations

Instrument	Description	Confidence	Evidence
ELAN-DEBT	Debt stack $4.4B	90%	Market cache reports total debt of $4.4B.

Elanco Animal Health Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Elanco Animal Health Incorporated.

Elanco Animal Health Incorporated Ownership

Holder	Name	Confidence	Evidence
ELAN-OWNER-DODGE-COX	Dodge & Cox	90%	13F overlay lists Dodge & Cox as top holder; 519 tracked holders.

Elanco Animal Health Incorporated Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ACIU	AC Immune SA	100.00	2
IMNM	Immunome, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
BYSI	BeyondSpring Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2
CRIS	Curis, Inc.	100.00	2
BX	Blackstone Inc.	100.00	1	['customer']
NVO	Novo Nordisk A/S	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
ALEC	Alector, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
ACRS	Aclaris Therapeutics, Inc.	100.00	2
FHTX	Foghorn Therapeutics Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
AXSM	Axsome Therapeutics, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AKTS	Aktis Oncology, Inc.	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
DAWN	Day One Biopharmaceuticals Inc	100.00	2
INCY	Incyte Corporation	100.00	2

Elanco Animal Health Incorporated Supply Chain